adalimumab
abbvie
['ibd', 'ease,(-please),(-disease),(-incrrease),(-decrease)', 'ada ', ' ada ']
rca van linschoten presenting a rct on clinical outcomes of increased vs conventional ada dose intervals in stable remission in cd. - ada intervals not inferior for persistent flares
but
-increased immunogenicity
- scape meds
- clinical rem #ibd #uegweek #uegweek22 
Celebrate life. Gastroenterologist. IBD. WGH Edinburgh/Zaragoza-Spain.I share my slides in @ibdeii